首页 | 本学科首页   官方微博 | 高级检索  
   检索      


A novel neuropeptide,pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprung's disease
Authors:Zhenxin Shen  Lars Torsten Larsson  Gerhard Malmfors  Afaf Absood  Rolf Håkanson  Frank Sundler
Institution:(1) Department of Pediatric Surgery, University of Lund, S-22185 Lund, Sweden;(2) Department of Medical Cell Research, University of Lund, S-22185 Lund, Sweden;(3) Department of Pharmacology, University of Lund, S-22185 Lund, Sweden
Abstract:Summary A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), exhibits sequence homology with vasoactive intestinal polypeptide (VIP) and occurs in the mammalian brain, lung and gut. The distribution of PACAP in ganglionic and aganglionic portions of the large intestine of patients with Hirschsprung's disease was examined by immunohistochemistry and radioimmunoassay. PACAP-immunoreactive nerve fibers were distributed in all layers of the ganglionic and aganglionic segments of the intestine, although they were less numerous in the latter, and PACAP-immunoreactive nerve cell bodies were seen in the ganglionic portion of the intestine. The concentration of immunoreactive PACAP was lower in the aganglionic than in the ganglionic segment of the intestinal wall. PACAP and VIP were found to coexist in both ganglionic and aganglionic segments of the intestine. Apparently, PACAP participates in the regulation of gut motility. The scarcer PACAP innervation of the aganglionic segment may contribute to the defect in intestinal relaxation seen in patients with Hirschsprung's disease.
Keywords:Pituitary adenylate cyclase-activating polypeptide (PACAP)  Vasoactive intestinal polypeptide  Neuropeptide immunocytochemistry  Radioimmunoassay  Hirschsprung's disease  Intestine  large  GUT motility  Human
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号